Asset Details
Do you wish to reserve the book?
Mycosis fungoides refractory to treatment – importance of a multidisciplinary approach
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mycosis fungoides refractory to treatment – importance of a multidisciplinary approach
Do you wish to request the book?
Mycosis fungoides refractory to treatment – importance of a multidisciplinary approach
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Mycosis fungoides refractory to treatment – importance of a multidisciplinary approach
2024
Overview
We report a case of difficult-to-control mycosis fungoides (MF), where the role of the dental surgeon was crucial for the control and prognosis of the disease. A 62-year-old female patient diagnosed with MF had a previous record of red patches and small raised bumps on the face, along with a cancerous growth in the cervical and vulvar region. The patient was initially treated with methotrexate and local radiotherapy without resolution. Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone was then started (CHOP protocol). The dental team of a reference hospital was consulted to evaluate swelling in the anterior region of the palate, which had been developing for two months, reporting discomfort when eating. The role of the dentistry team was fundamental in the differential diagnosis of oral lesions with dental infections, second neoplasia, or even a new site of disease manifestation, in addition to controlling mucosal changes resulting from chemotherapy. After ruling out dental infection, the dentistry team performed a lesion biopsy to confirm the diagnosis. The histopathological and immunohistochemical analysis showed atypical lymphoid infiltration of T cells (CD3+/CD4+/CD7-/CD8-), coexpression of CD25, and presence of CD30 cells, corresponding to the finding for MF. Identifying CD30 + allowed for a new chemotherapy protocol with brentuximab vedotin (BV) combined with gemcitabine. This protocol effectively controlled MF, which previous protocols had failed to do. The diagnosis by the dental team was essential for therapeutic change and improvement of the patient’s clinical condition without the need for invasive medical procedures.
Publisher
Springer Berlin Heidelberg,Springer Nature B.V
Subject
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
/ Brentuximab Vedotin - therapeutic use
/ Cyclophosphamide - therapeutic use
/ Doxorubicin - therapeutic use
/ Female
/ Humans
/ Medicine
/ Mycosis Fungoides - drug therapy
/ Mycosis Fungoides - pathology
/ Oral and Maxillofacial Surgery
/ Palatal Neoplasms - drug therapy
/ Palatal Neoplasms - pathology
/ Prednisone - therapeutic use
/ Protocol
